Gang Lin
- Weill Cornell Medicine · Microbiology & Immunology (NIH department code)
From the FY2025 NIH awards this investigator leads as contact PI. The department is the award's.
FY2025 NIH rank #5,782
- R01 Holder
- Early Career
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 10356821Search this ID in NIH RePORTER
- ORCID iD
- https://orcid.org/0000-0003-4797-7073Verified identifier for this researcher
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
FY2026 award categories
- Microbiology & Immunology
NIH Funding · FY2025
Linked Award Amount
$2.2M
Full award amounts, FY2025
Award Records
3
Records listing this PI
Award-Linked Rank
#5,782
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2025 award records by amount
NIH award records listing Gang Lin as a PI. Multi-PI records show the full award amount for context.
- 5R01AI143714-07R01Contact PISelective Plasmodium proteasome inhibitors as novel multi-stage antimalarialsWeill Cornell Medicine · Microbiology & Immunology (NIH department code)$798.3Kaward amount
- 5R01AI177635-03R01Contact PIHijacking Plasmodium ubiquitin-proteasome system to defeat drug resistanceWeill Cornell Medicine · Microbiology & Immunology (NIH department code)$749.8Kaward amount
- 5R01CA276053-02R01Contact PINovel proteasome inhibitors targeting both beta5 and beta2 subunits for treatment of triple negative breast cancerWeill Cornell Medicine · Microbiology & Immunology (NIH department code)$643.8Kaward amount
Award organization
Organizations that administered FY2025 awards listing Gang Lin as a PI.
FY2025 award administered by Weill Cornell Medicine (NY).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardWeill Cornell Medicine
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024$2M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #4082
- 2024Entered Top 25% NationallyRanked #4082
- 2025R01 Grant Holder
- 2026$5M Cumulative Funding